Found 60 matching trials
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer PHASE1 The purpose of this study is to determine the safety, tolerability and phar...
Show More Location
ATTN-Research Pharmacist
Learn More & Join Trial
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) PHASE2 The primary objective in this study is to evaluate bone scan response at We...
Show More Location
Multiple Locations
Learn More & Join Trial
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer PHASE3 The aim is to investigate whether the addition of short-term androgen depri...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer PHASE1 This is a global, multi-center, open-label, randomized phase 1b/2, active-c...
Show More Location
Genesis Healthcare Partners
Learn More & Join Trial
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) PHASE2 Single-arm, single site, open label study of the effects of parenteral test...
Show More Location
Sibley Memorial Hospital
Learn More & Join Trial
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. PHASE2 The investigators have used national VHA data to demonstrate real-world eff...
Show More Location
VA Greater Los Angeles Healthcare System
Learn More & Join Trial
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate PHASE2 This study is comparing the effectiveness of enzalutamide with or without a...
Show More Location
Johns Hopkins University
Learn More & Join Trial
COMbination of Bipolar Androgen Therapy and Nivolumab PHASE2 Single arm, multicenter, open-label Phase II study of the effects of parent...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment PHASE4 The purpose of the study was to understand if there is benefit in treatment...
Show More Learn More & Join Trial
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) PHASE1 The purpose of this study is to assess the safety and efficacy of pembroliz...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial